ORIENTBIO Inc. Cash Flow Conversion Efficiency

Latest as of December 2025: 0.026x

ORIENTBIO Inc. cash flow conversion efficiency. Based on the latest financial reports, ORIENTBIO Inc. (002630) has a cash flow conversion efficiency ratio of 0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.77 Billion ≈ $1.20 Million USD) by net assets (₩67.73 Billion ≈ $45.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of ORIENTBIO Inc. (2007–2025)

Cash flow conversion efficiency of ORIENTBIO Inc. from 2007 to 2025. This chart illustrates how ORIENTBIO Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest ORIENTBIO Inc. stock price today for real-time trading data and today's change.

ORIENTBIO Inc. Cash Flow Conversion Ratio Explained

ORIENTBIO Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ORIENTBIO Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ORIENTBIO Inc. ranked by their cash flow conversion efficiency. Also see 002630 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
UNITRAD KLSE:0247	-0.045x
Adverum Biotechnologies Inc NASDAQ:ADVM	0.505x
Virco Manufacturing Corporation NASDAQ:VIRC	-0.091x
Yoosung T&S Co. Ltd KQ:024800	0.004x
Laiqon AG XETRA:LQAG	0.037x
Neumora Therapeutics, Inc. NASDAQ:NMRA	-0.353x
Interlink Telecom Public Company Limited BK:ITEL	-0.022x
Silla Co.Ltd KO:004970	0.023x

Annual Cash Flow Conversion Efficiency for ORIENTBIO Inc. (2007–2025)

The table below shows the annual cash flow conversion efficiency of ORIENTBIO Inc. from 2007 to 2025. Review 002630 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	₩71.85 Billion ≈ $48.69 Million	₩752.29 Million ≈ $509.82K	0.010x	-76.28%
2024-03-31	₩85.10 Billion ≈ $57.67 Million	₩3.76 Billion ≈ $2.55 Million	0.044x	+171.70%
2023-03-31	₩71.39 Billion ≈ $48.38 Million	₩1.16 Billion ≈ $786.07K	0.016x	-42.52%
2022-03-31	₩83.19 Billion ≈ $56.38 Million	₩2.35 Billion ≈ $1.59 Million	0.028x	-84.30%
2021-03-31	₩48.55 Billion ≈ $32.90 Million	₩8.74 Billion ≈ $5.92 Million	0.180x	+339.61%
2020-03-31	₩51.96 Billion ≈ $35.21 Million	₩-3.90 Billion ≈ $-2.65 Million	-0.075x	+59.21%
2019-03-31	₩62.65 Billion ≈ $42.45 Million	₩-11.54 Billion ≈ $-7.82 Million	-0.184x	-648.68%
2018-03-31	₩79.92 Billion ≈ $54.16 Million	₩-1.97 Billion ≈ $-1.33 Million	-0.025x	+52.82%
2017-03-31	₩97.94 Billion ≈ $66.38 Million	₩-5.11 Billion ≈ $-3.46 Million	-0.052x	-621.81%
2016-03-31	₩91.29 Billion ≈ $61.87 Million	₩912.43 Million ≈ $618.34K	0.010x	-58.01%
2015-03-31	₩67.35 Billion ≈ $45.64 Million	₩1.60 Billion ≈ $1.09 Million	0.024x	-32.14%
2014-03-31	₩61.85 Billion ≈ $41.91 Million	₩2.17 Billion ≈ $1.47 Million	0.035x	-57.12%
2013-03-31	₩62.29 Billion ≈ $42.21 Million	₩5.09 Billion ≈ $3.45 Million	0.082x	+71.95%
2011-03-31	₩65.49 Billion ≈ $44.38 Million	₩3.11 Billion ≈ $2.11 Million	0.048x	-68.59%
2010-03-31	₩61.77 Billion ≈ $41.86 Million	₩9.35 Billion ≈ $6.34 Million	0.151x	+347.50%
2007-03-31	₩44.86 Billion ≈ $30.40 Million	₩1.52 Billion ≈ $1.03 Million	0.034x	--

About ORIENTBIO Inc.

KO:002630 Korea Biotechnology

Market Cap

$96.19 Million

₩141.94 Billion KRW

Market Cap Rank

#19167 Global

#929 in Korea

Share Price

₩1197.00

Change (1 day)

+1.96%

52-Week Range

₩467.00 - ₩1855.00

All Time High

₩6770.89